AVEO Oncology
AVEO
#7408
Rank
A$0.78 B
Marketcap
A$22.53
Share price
0.00%
Change (1 day)
164.69%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -A$40.76 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are A$94.31 Million. In 2021 the company made an earning of -A$80.12 Million a decrease over its 2020 earnings that were of -A$53.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -A$40.76 Million-49.12%
2021 -A$80.12 Million49.9%
2020 -A$53.45 Million-479.04%
2019 A$14.09 M-276.17%
2018 -A$8.01 Million-91.79%
2017 -A$97.51 Million142.38%
2016 -A$40.23 Million78.51%
2015 -A$22.54 Million-71.55%
2014 -A$79.21 Million-50.72%
2013 -A$0.17 Billion-4.88%
2012 -A$0.17 Billion-426.29%
2011 A$51.79 M-159.85%
2010 -A$86.55 Million35.33%
2009 -A$63.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
A$52.21 B-119,832.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$16.59 B-38,159.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$0.66 B-1,632.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$8.54 B-19,683.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$17.01 B-39,123.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-A$3.4 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA